Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Caladrius Biosciences
Biotech
Supply chain challenges upend Caladrius' heart drug trial
As Caladrius Biosciences merges with Cend Therapeutics to become Lisata Therapeutics, it’s leaving a coronary artery disease trial by the wayside.
Annalee Armstrong
May 24, 2022 10:00am
Moderna plucks Merck marketing head for CCO job—Chutes & Ladders
Apr 29, 2022 9:00am
Caladrius and Cend merge into tumor-focused Lisata Therapeutics
Apr 27, 2022 10:05am
AHA: Caladrius therapy helps heart disease that hits women
Nov 18, 2019 8:33am
